Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Bobs farmaceuter AB
AB
Active
Org 5593476327
Irisgatan 22
Retail sale of pharmaceutical products · NACE 4773
Est. 2021
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 681K
-51% vs 2023
EBITDA margin
25.5%
-79% vs 2023
Equity ratio
34.0%
Financial strength
Net profit 2024
SEK 103K
-79% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2022
1M
0%
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
SEK 681K
-51%
EBITDA
SEK 174K
-79%
Net profit
SEK 103K
-79%
Total assets
SEK 1,3M
-6%
Equity
SEK 442K
-17%
Employees
0
—
Company information
Legal name
Bobs farmaceuter AB
Org number
5593476327
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
22 november 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva apoteksverksamhet och bedriva bemanning av farmaceuter.
Contact
Address
Irisgatan 22
Email
info@bobs-farmaceuter.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Örebro
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
0M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
1 022
1 403
681
Staff expenses
−222
−476
−440
EBITDA
657
823
174
Depreciation & amort.
−4
−5
−9
EBIT
654
818
165
Net financials
0
−1
−2
Profit before tax
490
617
133
Tax
−101
−127
−29
Net profit
389
490
103
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
900
1 381
1 299
Equity
414
533
442
Long-term debt
—
—
—
Short-term debt
322
485
464
Total debt
322
485
464
Financial ratios
5-year trend
EBITDA margin
25.5%
This company
15.8%
Market median
+61% vs market
2022
2024
Equity ratio
34.0%
This company
38.2%
Market median
+11% vs market
2022
2024
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
2022
2024
Net profit margin
15.1%
This company
8.1%
Market median
+86% vs market
2022
2024
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
2022
2024
Debt / equity
1.94×
This company
0.62×
Market median
-213% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-11-22 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
NC
Nicoleta Crina Bob
Deputy Board Member
2022
FB
Fredrik Bob
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Bobs farmaceuter AB also hold positions in
0
other companies.
Person
Role here
Other companies
Nicoleta Crina Bob
Deputy Board Member
0 companies
Fredrik Bob
Board of Directors
0 companies